We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$105M
AUM Growth
+$31M
Cap. Flow
+$10.2M
Cap. Flow %
9.65%
Top 10 Hldgs %
37.42%
Holding
105
New
22
Increased
35
Reduced
19
Closed
22

Top Buys

Rank Stock Value
1
SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
+$6.61M
2
AGN.PRA
Allergan plc
AGN.PRA
+$1.98M
3
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$1.72M
4
CNC icon
Centene
CNC
+$1.44M
5
JD icon
JD.com
JD
+$1.26M

Top Sells

Rank Stock Value
1
KITE
Kite Pharma, Inc.
KITE
+$4.01M
2
UHS icon
Universal Health Services
UHS
+$1.84M
3
PCRX icon
Pacira BioSciences
PCRX
+$1.72M
4
MCK icon
McKesson
MCK
+$1.63M
5
BABA icon
Alibaba
BABA
+$1.15M

Sector Composition

Rank Sector Weight
1 Healthcare 43.3%
2 Miscellaneous 26.21%
3 Technology 14.09%
4 Communication Services 7.52%
5 Consumer Discretionary 5.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$489B
$8.23M 7.81%
56,600
+43,300
+326% +$6.2M
SNNA
2
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$6.7M 6.35%
+300,940
New +$6.61M
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$4.41M 4.18%
81,569
+29,300
+56% +$1.72M
PFE icon
4
CALL
Pfizer
PFE
$159B
$4.08M 3.87%
+120,367
New +$3.87M
XBI icon
5
CALL
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$3.4M 3.23%
+39,300
New +$3.15M
ELV icon
6
Elevance Health
ELV
$85.5B
$2.66M 2.52%
14,004
+1,470
+12% +$280K
PBYI icon
7
Puma Biotechnology
PBYI
$468M
$2.55M 2.42%
21,294
-7,988
-27% -$743K
GDDY icon
8
GoDaddy
GDDY
$12.4B
$2.53M 2.4%
58,091
+11,525
+25% +$497K
EW icon
9
Edwards Lifesciences
EW
$52B
$2.52M 2.39%
69,267
+27,453
+66% +$1.05M
META icon
10
Meta Platforms (Facebook)
META
$1.47T
$2.37M 2.25%
13,853
+6,902
+99% +$1.15M
BAX icon
11
Baxter International
BAX
$13.5B
$2.28M 2.17%
36,383
+9,628
+36% +$595K
ABT icon
12
Abbott
ABT
$195B
$2.13M 2.02%
39,888
+14,993
+60% +$752K
AMZN icon
13
Amazon
AMZN
$2.87T
$2.12M 2.01%
44,100
+17,400
+65% +$855K
CRM icon
14
Salesforce
CRM
$211B
$2.08M 1.97%
22,275
+12,356
+125% +$1.14M
GOOGL icon
15
Alphabet (Google) Class A
GOOGL
$4.24T
$1.97M 1.87%
40,400
+22,100
+121% +$1.05M
GDX icon
16
PUT
VanEck Gold Miners ETF
GDX
$31B
$1.93M 1.83%
+20,700
New +$478K
JD icon
17
JD.com
JD
$38.8B
$1.84M 1.74%
48,124
+29,505
+158% +$1.26M
MSFT icon
18
Microsoft
MSFT
$3.81T
$1.81M 1.72%
24,356
-1,628
-6% -$119K
CI icon
19
Cigna
CI
$73.7B
$1.77M 1.68%
9,466
+1,244
+15% +$221K
AGN.PRA
20
DELISTED
Allergan plc
AGN.PRA
$1.76M 1.67%
+2,383
New +$1.98M
ATVI
21
DELISTED
Activision Blizzard
ATVI
$1.67M 1.58%
25,856
+14,945
+137% +$932K
ZAYO
22
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$1.64M 1.55%
47,545
+23,357
+97% +$775K
CNC icon
23
Centene
CNC
$32B
$1.61M 1.53%
+33,336
New +$1.44M
AERI
24
DELISTED
Aerie Pharmaceuticals
AERI
$1.54M 1.46%
31,702
-794
-2% -$43.3K
BPMC
25
DELISTED
Blueprint Medicines
BPMC
$1.48M 1.41%
21,252
+2,630
+14% +$141K
1
2 3 4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q3 2017 Portfolio in Review

As of Q3 2017, Partner Investment Management held 105 positions worth $105M, up 42% from $74.4M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Partner Investment Management deployed $10.2M of net new capital in Q3 2017, opening 22 new positions and adding to 35 existing holdings. Its largest new stake was Sienna Biopharmaceuticals, Inc.: 300,940 shares worth $6.7M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 53% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was Kite Pharma, Inc., an estimated $4.01M trimmed.

  • Partner Investment Management's largest Q3 2017 buy was Sienna Biopharmaceuticals, Inc.: 300,940 shares worth $6.7M.
  • Partner Investment Management added most to Portola Pharmaceuticals, Inc. in Q3 2017, an estimated $1.72M increase.
  • Partner Investment Management's biggest Q3 2017 reduction was Kite Pharma, Inc., cutting an estimated $4.01M.
  • Partner Investment Management fully exited Universal Health Services in Q3 2017, selling an estimated $1.84M.
  • Partner Investment Management's ten largest holdings make up 37% of its $105M portfolio in Q3 2017.
  • Partner Investment Management opened 22 new positions and closed 22 in Q3 2017.
  • Partner Investment Management's portfolio value rose 42% quarter-over-quarter to $105M.

Based on Partner Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.